Seeking Alpha

Cephalon Inc. (CEPH)

()

News & PR
Market Currents

Buzz
Twitter: CEPH

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

30 'Magic Formula' Companies

Dec 16 • Value Expectations • 1 Comment
Weekly Wrap-Up: A Too-Early Bear?

Dec 14 • Philip Davis • Comment!
Will 2009's Losers Become 2010's Winners?

Dec 14 • Alan Brochstein • 6 Comments
Monday Options Recap

Nov 23 • Frederic Ruffy • 1 Comment
Biotech Stocks for a Possible Year-End Rally

Nov 18 • R. Scott Raynovich • 2 Comments
Monday Options Update: GLD, AMR, ANF, CEPH & ESV

Nov 9 • Andrew Wilkinson • 1 Comment
Cephalon's Upside and Downside

Nov 8 • MagicDiligence • Comment!
Wall Street Breakfast: Must-Know News

Oct 28 • SA Editor Eli Hoffmann • 14 Comments
Thursday Options Recap

Oct 22 • Frederic Ruffy • Comment!
Biotech: Q3 Market Update

Oct 16 • R. Scott Raynovich • 1 Comment
Biggest Money Makers and Losers Since 3/9/09

Oct 8 • TickerSense • 4 Comments
BioMed News Bytes: Dendreon, Chelsea, Cytori, Cephalon, OraSure, Genzyme, Lixte

Sep 25 • Mike Havrilla • 3 Comments
Identifying Large Cap Investment Opportunities

Sep 23 • Value Expectations • Comment!
Sales Growth Expectations for Attractive S&P 500 Stocks

Sep 15 • Value Expectations • Comment!
Ken Griffin's Citadel Fund: Options Eye Candy

Sep 10 • Market Folly • 2 Comments
The Biggest Losers

Sep 9 • Bespoke Investment Group • 1 Comment
Friday Options Recap

Sep 4 • Frederic Ruffy • 2 Comments
S&P 500: Solid Value Companies

Sep 3 • Value Expectations • Comment!
Spectrum Pharmaceuticals: The Labor Day Catalyst

Aug 20 • Justin M. Hall • 18 Comments
Highest Price Target Spreads for S&P 500 Stocks

Aug 14 • Bespoke Investment Group • Comment!
Incyte Presents Investors with Unique Dilemmas

Aug 10 • Ohad Hammer • 1 Comment
Who Will Buy Spectrum Pharmacueticals?

Aug 6 • Mark Cifra • 2 Comments
Wall Street Breakfast: Must-Know News

Aug 5 • SA Editor Rachael Granby • 11 Comments
Cephalon: Bullish Potential

Aug 4 • optionMONSTER • 1 Comment
P/E - Value Plays or Value Traps?

Jul 12 • Value Expectations • 5 Comments
Generic Players Continue to Impress in H1

Jul 2 • EP Vantage • Comment!
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG

Jul 1 • Mike Havrilla • 2 Comments
Our Monthly Buy / Sell List

Jun 29 • Value Expectations • Comment!
Cephalon Chugs Along, Despite Fentora, Provigil Setbacks

Jun 16 • Zacks.com • Comment!
S&P 500: Ten Stocks to Watch

Jun 11 • Value Expectations • Comment!
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly

May 27 • Mark Cifra • 4 Comments
Nasdaq 100 Stocks Up An Average of 20% YTD

May 20 • Bespoke Investment Group • 2 Comments
Top Ten S&P 500 Value Score Stocks

May 7 • Value Expectations • Comment!
Wall Street Breakfast: Must-Know News

May 6 • SA Editor Rachael Granby • 12 Comments
Cheap Stocks from the S&P 500

Apr 23 • Value Expectations • Comment!
A Look at D.E. Shaw's Q408 Holdings: Just for Fun

Apr 22 • Market Folly • 2 Comments
First Convertible Bond ETF Comes to Market

Apr 16 • Index Universe • 2 Comments
FDA Calendar Updates: Santarus, Cephalon, AstraZeneca, Dendreon, Gilead, Novo Nordisk

Apr 7 • Mike Havrilla • 1 Comment
Morphosys: A Biotech Rule Breaker (Part 2)

Mar 30 • Ohad Hammer • Comment!
2 Potential Pharma M&A Targets: Cephalon and Genzyme

Mar 23 • Bullish Bankers • 3 Comments
FDA and Clinical Trial Updates: United Therapeutics Faces Delays

Mar 18 • Mike Havrilla • 1 Comment

Cephalon Inc. (CEPH)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers